Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 290 | 2019 |
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 189 | 2019 |
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 188 | 2018 |
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial IS Mackenzie, CJ Hawkey, I Ford, N Greenlaw, F Pigazzani, A Rogers, ... The Lancet 400 (10359), 1195-1205, 2022 | 93 | 2022 |
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART … RAS Salman, DP Minks, D Mitra, MA Rodrigues, P Bhatnagar, ... The Lancet Neurology 18 (7), 643-652, 2019 | 91 | 2019 |
The association between prehospital care and in-hospital treatment decisions in acute stroke: a cohort study JP Sheppard, RM Mellor, S Greenfield, J Mant, T Quinn, D Sandler, ... Emergency Medicine Journal 32 (2), 93-99, 2015 | 73 | 2015 |
Decisions and delays within stroke patients’ route to the hospital: a qualitative study RM Mellor, S Bailey, J Sheppard, P Carr, T Quinn, A Boyal, D Sandler, ... Annals of emergency medicine 65 (3), 279-287. e3, 2015 | 65 | 2015 |
Incidence and impact on outcomes of acute kidney injury after a stroke: a systematic review and meta-analysis J Arnold, KP Ng, D Sims, P Gill, P Cockwell, C Ferro BMC nephrology 19, 1-10, 2018 | 48 | 2018 |
Modulation of stroke risk in chronic kidney disease J Arnold, D Sims, CJ Ferro Clinical kidney journal 9 (1), 29-38, 2016 | 42 | 2016 |
Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... JAMA neurology 78 (10), 1179-1186, 2021 | 39 | 2021 |
Cost-effectiveness of optimizing acute stroke care services for thrombolysis MC Penaloza-Ramos, JP Sheppard, S Jowett, P Barton, J Mant, T Quinn, ... Stroke 45 (2), 553-562, 2014 | 38 | 2014 |
Prevalence and predictors of hospital prealerting in acute stroke: a mixed methods study JP Sheppard, A Lindenmeyer, RM Mellor, S Greenfield, J Mant, T Quinn, ... Emergency Medicine Journal 33 (7), 482-488, 2016 | 15 | 2016 |
RApid primary care initiation of drug treatment for transient Ischaemic attack (RAPID− TIA): study protocol for a pilot randomised controlled trial D Edwards, K Fletcher, R Deller, R McManus, D Lasserson, M Giles, ... Trials 14, 1-12, 2013 | 11 | 2013 |
Acute kidney injury calculated using admission serum creatinine underestimates 30-day and 1-year mortality after acute stroke J Arnold, D Sims, P Gill, P Cockwell, C Ferro Clinical kidney journal 13 (1), 46-54, 2020 | 8 | 2020 |
on behalf of the Birmingham and Black Country Collaborations for Leadership in Applied Health Research and Care Investigators. Cost-effectiveness of optimizing acute stroke … MC Penaloza-Ramos, JP Sheppard, S Jowett, P Barton, J Mant, T Quinn, ... Stroke 45, 553-562, 2014 | 8 | 2014 |
The cost of providing mechanical thrombectomy in the UK NHS: a micro-costing study JS Balami, D Coughlan, PM White, P McMeekin, D Flynn, C Roffe, ... Clinical Medicine 20 (3), e40-e45, 2020 | 7 | 2020 |
Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease JJ Arnold, M Hayer, A Sharif, I Begaj, M Tabriez, D Bagnall, D Ray, ... BMJ open 5 (4), e006987, 2015 | 7 | 2015 |
The prevalence of bedrail use in British hospitals R Mildner, A Snell, A Arora, D Sims, E Wales Age and ageing 32 (5), 555-556, 2003 | 7 | 2003 |
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial SB Coutts, S Ankolekar, R Appireddy, JF Arenillas, Z Assis, P Bailey, ... The Lancet 403 (10444), 2597-2605, 2024 | 3 | 2024 |
When has service provision for transient ischaemic attack improved enough? A discrete event simulation economic modelling study P Barton, JP Sheppard, CM Penaloza-Ramos, S Jowett, GA Ford, ... BMJ open 7 (11), e018189, 2017 | 2 | 2017 |